Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
United Kingdom | Publication | November 2023
In June 2023, we reported that the Bank of England had announced the launch of its first system-wide exploratory scenario exercise and had published a related webpage.
As part of the exercise, the Bank asked a group of banks and non-bank financial institutions to provide information on how they react to turbulence in financial markets, such as the gilts crisis in autumn 2022.
The Bank hopes to enhance its understanding of the risks to and from these institutions, and their behaviour in stress, including what drives those behaviours. It also hopes to investigate how those behaviours and market dynamics can amplify shocks in markets and potentially pose risks to UK financial stability.
The Bank has now begun round one of the exercise by providing the participating institutions with details of a hypothetical stress scenario, together with response templates and guidance. Responses are expected by January 2024, with round two being run throughout the new year. A final report should be published by the end of 2024.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025